Health

Scholar analyzes the relation between federal regulation and assisted death initiatives.

Experts debate the role of pharmacy benefit managers in rising U.S. drug prices.

Scholars propose avenues to improving the regulation of clean food labels.

By second-guessing FDA safety determinations, the Fifth Circuit challenges the Supreme Court to restore agency deference.

Expert advocates a variety of policies that local governments can take to combat increasing fatalities from drug overdoses.

Patents covering drugs selected for Medicare price negotiation show how patents influence drug prices.

Experts recommend measures to improve the regulation of dietary supplements.

Biden Administration introduces price regulation to the pharmaceutical industry.

Researchers explore the optimal cost-benefit considerations of medical device cybersecurity risks.

Experts discuss how regulators can protect consumers from aggressive collection practices.

Scholar argues that generational amnesia may lead to ineffective regulatory solutions in the future.

Scholar argues that FDA should adopt an evidenced-based approach to regulating drug manufacturers’ speech.